LIVE MARKET TRACKER :   BSE SENSEX   31138.21      |    NSE NIFTY 9574.95    
GLOBAL MARKETS :  NASDAQ 6265.2495   +0.4580%    |    FSI London 7424.13   -0.20%    |    NIKKEI Japan 20132.67   +0.11%
  USD GBP EUR CAD AUD INR
USD - 0.7870 0.8937 1.3274 1.3181 64.5290
GBP 1.2719 - 1.1368 1.6883 1.6757 82.0797
EUR 1.1189 0.8801 - 1.4782 1.4736 72.1941
CAD 0.7552 0.5936 0.6749 - 0.9949 48.6810
AUD 0.7575 0.5973 0.6786 1.0066 - 48.9610
INR 0.0155 0.0122 0.0139 0.0206 0.0205 -
Indian-Commodity  :  Equity & Shares  :  Aurobindo Pharma gains on plans of launching 19 products in US in next three quarters

Aurobindo Pharma gains on plans of launching 19 products in US in next three quarters (06-Sep-2016)

Aurobindo Pharma is currently trading at Rs. 782.60, up by 3.60 points or 0.46% from its previous closing of Rs. 779.00 on the BSE.

The scrip opened at Rs. 784.70 and has touched a high and low of Rs. 787.00 and Rs. 778.40 respectively. So far 23150 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 1 has touched a 52 week high of Rs. 891.50 on 30-Dec-2015 and a 52 week low of Rs. 582.00 on 25-Feb-2016.

Last one week high and low of the scrip stood at Rs. 805.15 and Rs. 767.20 respectively. The current market cap of the company is Rs. 45889.00 crore.

The promoters holding in the company stood at 53.79%, while institutions and non-institutions held 34.08% and 12.13% respectively.

Aurobindo Pharma is planning to launch 19 approved products that have an addressable market of $6.8 billion in the US in the next three quarters. Moreover, the company has another 22 targeted 'action dates through the end of the financial year' although it does not 'anticipate all those will be final approvals but a significant number will be'.

Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.


Top News Today
Tata Steel sells stake in Tata Motors
(24-Jun-2017)

Tata Steel sells stake in Tata MotorsTata Steel has sold its stake in Tata Motors to Tata Sons, the holding company of India's salt-to-software Tata conglomerate, for Rs 37.83 billion ($586.3 million). The steelmaker has sold about 83.54......click on news to read complete article.

Crest Ventures acquires 6 lakh shares of Crest Wealth Management
(24-Jun-2017)

Crest Ventures acquires 6 lakh shares of Crest Wealth ManagementCrest Ventures (CVL) has acquired 6 lakh equity shares of Crest Wealth Management (CWMPL), its Subsidiary Company, from Mitesh Shah at a total consideration of Rs 43.20 lakh on June 23, 2017. Consequent......click on news to read complete article.

DPSC's arm to co-develop 12MW of solar assets in Uttarakhand
(24-Jun-2017)

DPSCDPSC's wholly owned subsidiary India Power Green Utility (IPGUPL) has agreed to co-develop 12MW of solar assets in Uttarakhand with Punj Lloyd Infrastructure (PLIL) to be executed by PL Surya Vidyut, the......click on news to read complete article.

International Stock News
US markets end mostly in green of Friday
(24-Jun-2017)

US markets end mostly in green of FridayThe US markets ended the choppy day of trade mostly in green on Friday, as traders took some support with report from the Commerce Department showing a rebound in new home sales in the month of May. The......click on news to read complete article.

US markets closed mostly lower on Thursday
(23-Jun-2017)

US markets closed mostly lower on ThursdayThe US markets closed mostly lower on Thursday, as weak financials and consumer staples shares eclipsed a rally in the health-care and biotechnology sectors. The Federal Reserve said that the 34 largest......click on news to read complete article.

US markets closed mostly lower; Nasdaq post moderate gains
(22-Jun-2017)

US markets closed mostly lower; Nasdaq post moderate gainsThe US markets closed lower on Wednesday, weighed down by losses in the energy sector as oil prices continued to slide. But the Nasdaq Composite posted moderate gains, thanks to a surge in biotechnology......click on news to read complete article.

 

     
  
Recent Equity & Shares News
 
EquityInvestmentCompany ReportsIPO
Disclaimer
By clicking on this page you accept all the terms and conditions framed by us. News made available here are for informational purpose only. While utmost care has been taken in providing the same. We claim no responsibility for its accuracy. Readers of this blog who make their decision based on the information posted here are solely responsible for their actions.